Eun-Kyoung Choi , Sun-Ah Park , Won-Mann Oh , Ho-Cheol Kang , Howard K. Kuramitsu , Byung-Gook Kim , In-Chol Kang
{"title":"Mechanisms of Porphyromonas gingivalis-induced monocyte chemoattractant protein-1 expression in endothelial cells","authors":"Eun-Kyoung Choi , Sun-Ah Park , Won-Mann Oh , Ho-Cheol Kang , Howard K. Kuramitsu , Byung-Gook Kim , In-Chol Kang","doi":"10.1016/j.femsim.2004.12.003","DOIUrl":null,"url":null,"abstract":"<div><p><span>Monocyte chemoattractant protein-1 (MCP-1) is expressed in vascular endothelial cells<span><span> of inflamed gingival tissues and plays an important role in periodontal pathogenesis. </span>Endothelial cells produce high levels of MCP-1 in response to </span></span><span><em>Porphyromonas gingivalis</em></span><span><span>, an important periodontal pathogen. The present study investigated the mechanisms involved in MCP-1 production by </span>human umbilical vein endothelial cells (HUVEC) following infection with </span><em>P. gingivalis</em>. In contrast to <span><em>P. gingivalis, </em><em>Bacteroides forsythus</em></span> only weakly stimulated MCP-1 production while <span><em>Treponema denticola</em></span><span> could not induce MCP-1 in HUVEC. The MCP-1 production was independent of endogenous interleukin (IL)-1α as IL-1 receptor antagonist treatment did not reduce MCP-1 production by </span><em>P. gingivalis</em><span>. Meanwhile, antioxidant treatment and inhibition of NAD(P)H oxidase significantly reduced MCP-1 production. Pharmacological inhibition of p38 mitogen-associated protein (MAP) kinase, c-Jun N-terminal kinase (JNK), nuclear factor-κB (NF-κB) or activator protein-1 (AP-1) also substantially attenuated </span><em>P. gingivalis</em>-induced MCP-1 expression by HUVEC. Indeed, activation of NF-κB and AP-1 was observed in <em>P. gingivalis</em>-infected HUVEC. These results suggest that MCP-1 expression is upregulated in <em>P. gingivalis</em>-infected endothelial cells via reactive oxygen species, p38 MAP kinase, JNK, NF-κB, and AP-1.</p></div>","PeriodicalId":12220,"journal":{"name":"FEMS immunology and medical microbiology","volume":"44 1","pages":"Pages 51-58"},"PeriodicalIF":0.0000,"publicationDate":"2005-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.femsim.2004.12.003","citationCount":"25","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"FEMS immunology and medical microbiology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0928824404002615","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 25
Abstract
Monocyte chemoattractant protein-1 (MCP-1) is expressed in vascular endothelial cells of inflamed gingival tissues and plays an important role in periodontal pathogenesis. Endothelial cells produce high levels of MCP-1 in response to Porphyromonas gingivalis, an important periodontal pathogen. The present study investigated the mechanisms involved in MCP-1 production by human umbilical vein endothelial cells (HUVEC) following infection with P. gingivalis. In contrast to P. gingivalis, Bacteroides forsythus only weakly stimulated MCP-1 production while Treponema denticola could not induce MCP-1 in HUVEC. The MCP-1 production was independent of endogenous interleukin (IL)-1α as IL-1 receptor antagonist treatment did not reduce MCP-1 production by P. gingivalis. Meanwhile, antioxidant treatment and inhibition of NAD(P)H oxidase significantly reduced MCP-1 production. Pharmacological inhibition of p38 mitogen-associated protein (MAP) kinase, c-Jun N-terminal kinase (JNK), nuclear factor-κB (NF-κB) or activator protein-1 (AP-1) also substantially attenuated P. gingivalis-induced MCP-1 expression by HUVEC. Indeed, activation of NF-κB and AP-1 was observed in P. gingivalis-infected HUVEC. These results suggest that MCP-1 expression is upregulated in P. gingivalis-infected endothelial cells via reactive oxygen species, p38 MAP kinase, JNK, NF-κB, and AP-1.